TERAZOSIN

TERAZOSIN was reported 8916 times

TERAZOSIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FORCED EXPIRATORY FLOW DECREASED 6 0.0619
1 EYE PARAESTHESIA 8 0.0510
2 ILIAC ARTERY STENOSIS 5 0.0379
3 MYASTHENIC SYNDROME 19 0.0245
4 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 23 0.0217
5 HERBAL INTERACTION 6 0.0166
6 HYPERPARATHYROIDISM SECONDARY 40 0.0159
7 NEPHROGENIC ANAEMIA 66 0.0142
8 MICTURITION FREQUENCY DECREASED 10 0.0133
9 PERIPHERAL ARTERY STENOSIS 6 0.0125
10 WHITE COAT HYPERTENSION 6 0.0111
11 LUNG HYPERINFLATION 9 0.0105
12 DIFFUSE ALVEOLAR DAMAGE 11 0.0096
13 MALIGNANT HYPERTENSION 8 0.0093
14 FORCED VITAL CAPACITY DECREASED 6 0.0092
15 HYPERTENSIVE URGENCY 5 0.0090
16 NON-CARDIOGENIC PULMONARY OEDEMA 9 0.0085
17 CERVICAL RADICULOPATHY 6 0.0084
18 BRADYARRHYTHMIA 13 0.0079
19 HYPOCHROMIC ANAEMIA 8 0.0079
20 END STAGE RENAL DISEASE 135 0.0074
21 TRANSPLANT DYSFUNCTION 13 0.0073
22 REBOUND ACID HYPERSECRETION 22 0.0073
23 METABOLIC SURGERY 8 0.0070
24 BLOOD PRESSURE DIASTOLIC ABNORMAL 17 0.0067
25 PRIMARY SEQUESTRUM 6 0.0066
26 GASTRIC ULCER PERFORATION 8 0.0063
27 PROSTATOMEGALY 24 0.0061
28 AORTIC ARTERIOSCLEROSIS 15 0.0058
29 DISTRIBUTIVE SHOCK 13 0.0057
30 PULSELESS ELECTRICAL ACTIVITY 23 0.0055
31 AORTIC DILATATION 6 0.0054
32 HEART VALVE INCOMPETENCE 15 0.0052
33 BENIGN PROSTATIC HYPERPLASIA 26 0.0050
34 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 8 0.0048
35 HAEMORRHAGIC ANAEMIA 21 0.0048
36 POTENTIATING DRUG INTERACTION 16 0.0048
37 HYPERTENSIVE EMERGENCY 5 0.0042
38 CHRONIC KIDNEY DISEASE 320 0.0042
39 CERVICAL SPINAL STENOSIS 7 0.0041
40 BLOOD PRESSURE SYSTOLIC ABNORMAL 10 0.0040
41 FOOD INTERACTION 7 0.0040
42 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 5 0.0039
43 ADENOCARCINOMA PANCREAS 5 0.0039
44 CAPILLARY LEAK SYNDROME 8 0.0039
45 URINARY BLADDER HAEMORRHAGE 8 0.0038
46 HYPOVOLAEMIA 22 0.0038
47 COMPUTERISED TOMOGRAM ABNORMAL 8 0.0035
48 BLOOD LOSS ANAEMIA 8 0.0035
49 AORTIC STENOSIS 12 0.0034
50 PAINFUL RESPIRATION 8 0.0033
51 METASTATIC RENAL CELL CARCINOMA 6 0.0033
52 ESSENTIAL HYPERTENSION 6 0.0033
53 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 8 0.0032
54 SNORING 12 0.0032
55 MECHANICAL VENTILATION 6 0.0032
56 HEPATIC NEOPLASM 10 0.0031
57 UPPER GASTROINTESTINAL HAEMORRHAGE 50 0.0030
58 NIPPLE PAIN 6 0.0029
59 ISCHAEMIC CARDIOMYOPATHY 9 0.0029
60 PERIPHERAL VASCULAR DISORDER 15 0.0029
61 KIDNEY FIBROSIS 5 0.0029
62 LOWER GASTROINTESTINAL HAEMORRHAGE 21 0.0028
63 RENAL INJURY 83 0.0028
64 MEAN CELL VOLUME INCREASED 7 0.0027
65 ARTERIOSCLEROSIS CORONARY ARTERY 18 0.0027
66 RIGHT VENTRICULAR FAILURE 19 0.0027
67 DIVERTICULUM 19 0.0027
68 SLEEP APNOEA SYNDROME 51 0.0027
69 ORTHOSTATIC HYPOTENSION 46 0.0026
70 BLOOD TESTOSTERONE DECREASED 18 0.0026
71 REGURGITATION 9 0.0026
72 BLOOD CREATININE ABNORMAL 9 0.0026
73 LEFT VENTRICULAR HYPERTROPHY 11 0.0026
74 GASTRIC PERFORATION 7 0.0026
75 BLOOD BLISTER 8 0.0026
76 ATRIOVENTRICULAR BLOCK COMPLETE 17 0.0025
77 NOCTURIA 30 0.0025
78 HAEMATOLOGICAL INFECTION 6 0.0025
79 DEAFNESS NEUROSENSORY 8 0.0024
80 MYOPATHY 21 0.0024
81 BLOOD PRESSURE SYSTOLIC INCREASED 47 0.0024
82 BODY TEMPERATURE FLUCTUATION 5 0.0024
83 THORACIC VERTEBRAL FRACTURE 7 0.0024
84 PERFORMANCE STATUS DECREASED 11 0.0024
85 PROSTATIC DISORDER 13 0.0024
86 URINE ANALYSIS ABNORMAL 7 0.0023
87 MYOSITIS 21 0.0023
88 ACUTE KIDNEY INJURY 357 0.0023
89 PHYSICAL DECONDITIONING 6 0.0023
90 EMERGENCY CARE 7 0.0023
91 RENAL FAILURE 303 0.0023
92 COLONOSCOPY 5 0.0023
93 INTERVERTEBRAL DISC DEGENERATION 21 0.0023
94 RALES 13 0.0022
95 BONE LESION 8 0.0022
96 HYPERKALAEMIA 77 0.0022
97 CAROTID ARTERY OCCLUSION 8 0.0022
98 LICHENOID KERATOSIS 5 0.0022
99 SPINAL STENOSIS 9 0.0022
100 PLEURITIC PAIN 6 0.0022
101 SINUS BRADYCARDIA 21 0.0022
102 RED CELL DISTRIBUTION WIDTH INCREASED 9 0.0022
103 RENAL TUBULAR DISORDER 6 0.0021
104 INGROWING NAIL 5 0.0021
105 SARCOIDOSIS 10 0.0021
106 PROSTATIC SPECIFIC ANTIGEN INCREASED 29 0.0021
107 BLOOD GLUCOSE FLUCTUATION 23 0.0021
108 TUBULOINTERSTITIAL NEPHRITIS 39 0.0021
109 GOUT 37 0.0021
110 IDIOPATHIC PULMONARY FIBROSIS 8 0.0020
111 GASTROINTESTINAL HAEMORRHAGE 168 0.0020
112 PROSTATITIS 6 0.0020
113 DIABETIC FOOT 6 0.0020
114 DIZZINESS POSTURAL 19 0.0020
115 BLOOD PRESSURE FLUCTUATION 47 0.0020
116 CANCER PAIN 5 0.0020
117 BRAIN NATRIURETIC PEPTIDE INCREASED 6 0.0019
118 BRONCHIECTASIS 13 0.0019
119 BLOOD PRESSURE DIASTOLIC DECREASED 14 0.0019
120 SPLENOMEGALY 22 0.0019
121 BLOOD POTASSIUM ABNORMAL 5 0.0019
122 HUMERUS FRACTURE 9 0.0019
123 ATELECTASIS 18 0.0019
124 IRON DEFICIENCY ANAEMIA 17 0.0018
125 RENAL TUBULAR NECROSIS 18 0.0018
126 BLOOD PRESSURE INADEQUATELY CONTROLLED 11 0.0018
127 SQUAMOUS CELL CARCINOMA OF SKIN 11 0.0018
128 LACTIC ACIDOSIS 59 0.0018
129 OBESITY 29 0.0018
130 DIABETIC NEUROPATHY 9 0.0018
131 INGUINAL HERNIA 11 0.0018
132 ROTATOR CUFF SYNDROME 23 0.0018
133 GLOMERULAR FILTRATION RATE DECREASED 22 0.0018
134 DUODENAL ULCER HAEMORRHAGE 5 0.0017
135 PULMONARY MASS 26 0.0017
136 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
137 PRIAPISM 6 0.0017
138 DYSURIA 64 0.0017
139 HYPERBILIRUBINAEMIA 18 0.0017
140 EXERCISE TOLERANCE DECREASED 10 0.0017
141 FINE MOTOR SKILL DYSFUNCTION 5 0.0017
142 HYPERVENTILATION 10 0.0017
143 HAEMOTHORAX 5 0.0017
144 EXTRASYSTOLES 12 0.0017
145 ECONOMIC PROBLEM 26 0.0017
146 ANHEDONIA 45 0.0017
147 UMBILICAL HERNIA 8 0.0017
148 NECROTISING FASCIITIS 6 0.0017
149 SPINAL COLUMN STENOSIS 8 0.0017
150 WALKING AID USER 11 0.0017
151 METABOLIC ENCEPHALOPATHY 5 0.0017
152 BACK DISORDER 27 0.0017
153 FINGER DEFORMITY 8 0.0016
154 PRESYNCOPE 40 0.0016
155 PSEUDOMONAS INFECTION 14 0.0016
156 HYPERKERATOSIS 9 0.0016
157 DUODENITIS 5 0.0016
158 WOUND HAEMORRHAGE 6 0.0016
159 PROTEIN URINE PRESENT 8 0.0016
160 BASAL CELL CARCINOMA 25 0.0016
161 DIVERTICULUM INTESTINAL 7 0.0016
162 BLOOD CREATININE DECREASED 5 0.0016
163 SQUAMOUS CELL CARCINOMA 15 0.0016
164 PHYSICAL DISABILITY 7 0.0016
165 BLOOD CREATINE INCREASED 7 0.0016
166 HYPOTHERMIA 16 0.0016
167 TONGUE OEDEMA 6 0.0016
168 DRUG LEVEL DECREASED 16 0.0016
169 LOOSE TOOTH 5 0.0016
170 BLOOD PRESSURE SYSTOLIC DECREASED 7 0.0015
171 LUMBAR VERTEBRAL FRACTURE 7 0.0015
172 POLYDIPSIA 6 0.0015
173 OSTEOPENIA 23 0.0015
174 HAEMATOCRIT DECREASED 30 0.0015
175 RENAL FUNCTION TEST ABNORMAL 7 0.0015
176 ATRIAL FLUTTER 12 0.0015
177 AZOTAEMIA 6 0.0015
178 COAGULOPATHY 25 0.0015
179 MALIGNANT MELANOMA 20 0.0015
180 DECREASED ACTIVITY 16 0.0015
181 HEART RATE DECREASED 52 0.0015
182 RIB FRACTURE 30 0.0015
183 PRE-EXISTING CONDITION IMPROVED 9 0.0014
184 NASAL DRYNESS 9 0.0014
185 CAROTID ARTERY STENOSIS 5 0.0014
186 HYPERVOLAEMIA 7 0.0014
187 RENAL PAIN 15 0.0014
188 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 24 0.0014
189 APNOEA 11 0.0014
190 INTERNAL HAEMORRHAGE 16 0.0014
191 ARTERIAL OCCLUSIVE DISEASE 11 0.0014
192 BRADYCARDIA 74 0.0014
193 SKIN CANCER 30 0.0014
194 KLEBSIELLA INFECTION 7 0.0014
195 SPUTUM DISCOLOURED 13 0.0014
196 WOUND INFECTION 15 0.0014
197 PROTEINURIA 26 0.0014
198 SPINAL OSTEOARTHRITIS 12 0.0014
199 HAEMOPTYSIS 38 0.0014
200 DIALYSIS 19 0.0013
201 HEARING IMPAIRED 8 0.0013
202 FULL BLOOD COUNT ABNORMAL 14 0.0013
203 CORONARY ARTERY DISEASE 40 0.0013
204 BODY TEMPERATURE DECREASED 13 0.0013
205 BLOOD COUNT ABNORMAL 20 0.0013
206 WHEEZING 78 0.0013
207 HIATUS HERNIA 17 0.0013
208 CORONARY ARTERY OCCLUSION 18 0.0013
209 GASTRIC INFECTION 5 0.0013
210 RESPIRATION ABNORMAL 9 0.0013
211 ACUTE RESPIRATORY DISTRESS SYNDROME 23 0.0013
212 BLOOD CHOLESTEROL ABNORMAL 6 0.0013
213 POLLAKIURIA 54 0.0013
214 ATRIOVENTRICULAR BLOCK 10 0.0013
215 HYPOTENSION 259 0.0013
216 BACK INJURY 14 0.0013
217 NEPHROPATHY 12 0.0013
218 EPIGASTRIC DISCOMFORT 5 0.0013
219 CARDIAC OPERATION 11 0.0013
220 TIBIA FRACTURE 6 0.0013
221 IMMUNODEFICIENCY 19 0.0013
222 MUSCLE STRAIN 11 0.0013
223 LEUKOCYTOSIS 23 0.0013
224 HAEMORRHAGE INTRACRANIAL 19 0.0013
225 INITIAL INSOMNIA 13 0.0013
226 PHOTOPSIA 8 0.0013
227 ATRIAL FIBRILLATION 123 0.0013
228 RENAL CYST 10 0.0013
229 HAEMATURIA 43 0.0013
230 HYPOVOLAEMIC SHOCK 6 0.0013
231 HYPOPHAGIA 32 0.0013
232 KIDNEY TRANSPLANT REJECTION 6 0.0012
233 LUNG INFILTRATION 11 0.0012
234 HAEMOGLOBIN ABNORMAL 8 0.0012
235 GALLBLADDER DISORDER 22 0.0012
236 ANGINA UNSTABLE 8 0.0012
237 URINARY RETENTION 41 0.0012
238 RENAL CELL CARCINOMA 6 0.0012
239 MICTURITION URGENCY 14 0.0012
240 CARDIOVASCULAR DISORDER 31 0.0012
241 VITREOUS FLOATERS 12 0.0012
242 MUSCULOSKELETAL DISCOMFORT 21 0.0012
243 CARDIOMEGALY 15 0.0012
244 SHOCK 28 0.0012
245 DYSPNOEA EXERTIONAL 45 0.0012
246 CORONARY ARTERY STENOSIS 6 0.0012
247 METASTASES TO LYMPH NODES 8 0.0012
248 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 6 0.0012
249 PLEURAL EFFUSION 72 0.0012
250 PATHOLOGICAL FRACTURE 6 0.0012
251 CARDIAC FAILURE CHRONIC 5 0.0012
252 FOOT DEFORMITY 13 0.0012
253 RENAL FAILURE CHRONIC 9 0.0012
254 SYNCOPE 117 0.0012
255 ARTERIOSCLEROSIS 11 0.0012
256 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 56 0.0012
257 SINUS DISORDER 23 0.0012
258 ORAL PAIN 26 0.0012
259 POOR VENOUS ACCESS 12 0.0012
260 BLOOD MAGNESIUM DECREASED 10 0.0012
261 LUNG INFECTION 18 0.0012
262 REBOUND EFFECT 13 0.0011
263 WEIGHT FLUCTUATION 12 0.0011
264 ACUTE RESPIRATORY FAILURE 22 0.0011
265 BLOOD UREA INCREASED 19 0.0011
266 BLOOD PRESSURE INCREASED 173 0.0011
267 ISCHAEMIC STROKE 20 0.0011
268 HOSPICE CARE 11 0.0011
269 GINGIVITIS 6 0.0011
270 MUSCLE DISORDER 9 0.0011
271 MUSCLE TIGHTNESS 18 0.0011
272 POLYURIA 9 0.0011
273 FAECALOMA 6 0.0011
274 MOUTH HAEMORRHAGE 8 0.0011
275 MACULAR DEGENERATION 13 0.0011
276 BLOOD CREATININE INCREASED 71 0.0011
277 INTERNATIONAL NORMALISED RATIO INCREASED 31 0.0011
278 HERNIA 21 0.0011
279 BLOOD PRESSURE DIASTOLIC INCREASED 5 0.0011
280 LOCALISED OEDEMA 5 0.0011
281 GASTRITIS EROSIVE 5 0.0011
282 HYPOGLYCAEMIA 52 0.0011
283 POLYP 7 0.0011
284 INCORRECT DRUG ADMINISTRATION DURATION 30 0.0011
285 SOMNAMBULISM 7 0.0011
286 RHABDOMYOLYSIS 44 0.0011
287 AORTIC ANEURYSM 8 0.0011
288 TROPONIN INCREASED 8 0.0011
289 SUBDURAL HAEMATOMA 15 0.0010
290 CORONARY ARTERY BYPASS 6 0.0010
291 HAEMOGLOBIN DECREASED 107 0.0010
292 BLOOD URIC ACID INCREASED 6 0.0010
293 RENAL FAILURE ACUTE 44 0.0010
294 CONCUSSION 8 0.0010
295 FLUID OVERLOAD 15 0.0010
296 TACHYPNOEA 14 0.0010
297 EOSINOPHILIA 18 0.0010
298 PULMONARY HAEMORRHAGE 8 0.0010
299 ACUTE MYOCARDIAL INFARCTION 30 0.0010
300 PURPURA 9 0.0010
301 BLOOD IRON DECREASED 12 0.0010
302 BLOOD ALBUMIN DECREASED 8 0.0010
303 BLOOD SODIUM DECREASED 19 0.0010
304 BLADDER DISORDER 10 0.0010
305 TRICUSPID VALVE INCOMPETENCE 8 0.0010
306 CARDIAC PACEMAKER INSERTION 6 0.0010
307 HYPERNATRAEMIA 5 0.0010
308 MASS 14 0.0010
309 BLOOD URINE PRESENT 19 0.0010
310 ENDOPHTHALMITIS 6 0.0010
311 FLUID INTAKE REDUCED 5 0.0010
312 CARDIAC FAILURE CONGESTIVE 80 0.0010
313 OSTEOMYELITIS 18 0.0010
314 MYASTHENIA GRAVIS 8 0.0010
315 OBSTRUCTIVE AIRWAYS DISORDER 11 0.0010
316 HYPERTENSIVE CRISIS 11 0.0010
317 PULMONARY CONGESTION 13 0.0010
318 PNEUMONIA BACTERIAL 9 0.0010
319 HEAD INJURY 31 0.0010
320 INCREASED TENDENCY TO BRUISE 9 0.0010
321 RECTAL HAEMORRHAGE 42 0.0010
322 ASTHENIA 367 0.0010
323 NERVE COMPRESSION 9 0.0010
324 SMALL INTESTINAL OBSTRUCTION 12 0.0010
325 CELLULITIS 49 0.0010
326 MITRAL VALVE INCOMPETENCE 11 0.0010
327 PHARYNGITIS 12 0.0010
328 HEMIPLEGIA 8 0.0010
329 TRANSFUSION 10 0.0010
330 EPISTAXIS 71 0.0009
331 RED BLOOD CELL COUNT DECREASED 27 0.0009
332 RENAL IMPAIRMENT 79 0.0009
333 SUNBURN 7 0.0009
334 PROCTALGIA 6 0.0009
335 OXYGEN SATURATION DECREASED 52 0.0009
336 DYSSTASIA 27 0.0009
337 CHEILITIS 5 0.0009
338 BLOOD POTASSIUM INCREASED 15 0.0009
339 FAECES DISCOLOURED 20 0.0009
340 HYPERLIPIDAEMIA 11 0.0009
341 OSTEOARTHRITIS 39 0.0009
342 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 48 0.0009
343 TRANSIENT ISCHAEMIC ATTACK 31 0.0009
344 HAEMODYNAMIC INSTABILITY 7 0.0009
345 BRADYPHRENIA 6 0.0009
346 HYPERTENSION 194 0.0009
347 HALLUCINATION 69 0.0009
348 URINARY INCONTINENCE 27 0.0009
349 UPPER RESPIRATORY TRACT INFECTION 42 0.0009
350 INJECTION SITE NODULE 10 0.0009
351 DEHYDRATION 121 0.0009
352 TOOTH FRACTURE 10 0.0009
353 HYPERGLYCAEMIA 33 0.0009
354 FLUID RETENTION 46 0.0009
355 GASTRIC ULCER HAEMORRHAGE 5 0.0009
356 RENAL DISORDER 42 0.0009
357 LEFT VENTRICULAR DYSFUNCTION 6 0.0009
358 EMPHYSEMA 9 0.0009
359 TENDON RUPTURE 11 0.0009
360 BALANCE DISORDER 77 0.0009
361 BLOOD PRESSURE DECREASED 59 0.0009
362 GINGIVAL BLEEDING 12 0.0009
363 BONE DISORDER 16 0.0009
364 EXOSTOSIS 8 0.0009
365 ECCHYMOSIS 6 0.0009
366 CARDIAC VALVE DISEASE 5 0.0009
367 NEPHROLITHIASIS 40 0.0009
368 RHINITIS 7 0.0009
369 STENT PLACEMENT 7 0.0009
370 VENTRICULAR EXTRASYSTOLES 9 0.0009
371 LARGE INTESTINE POLYP 6 0.0009
372 FALL 288 0.0009
373 COORDINATION ABNORMAL 12 0.0009
374 PRODUCTIVE COUGH 41 0.0009
375 GASTROOESOPHAGEAL REFLUX DISEASE 69 0.0009
376 HICCUPS 7 0.0009
377 INCONTINENCE 9 0.0009
378 BLINDNESS UNILATERAL 12 0.0008
379 HAIR DISORDER 7 0.0008
380 DECREASED INTEREST 5 0.0008
381 SPINAL COMPRESSION FRACTURE 7 0.0008
382 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
383 OEDEMA PERIPHERAL 103 0.0008
384 FULL BLOOD COUNT DECREASED 17 0.0008
385 AGEUSIA 21 0.0008
386 BODY HEIGHT DECREASED 9 0.0008
387 HIP FRACTURE 27 0.0008
388 DRUG INTERACTION 133 0.0008
389 TOOTH INFECTION 11 0.0008
390 TYPE 2 DIABETES MELLITUS 28 0.0008
391 OEDEMA 45 0.0008
392 MENTAL STATUS CHANGES 23 0.0008
393 LOCALISED INFECTION 20 0.0008
394 CONSTIPATION 180 0.0008
395 ASPIRATION 9 0.0008
396 VITAMIN D DEFICIENCY 8 0.0008
397 PLASMA CELL MYELOMA 32 0.0008
398 BLINDNESS TRANSIENT 6 0.0008
399 HYPOPHOSPHATAEMIA 6 0.0008
400 CARDIAC ARREST 67 0.0008
401 FLATULENCE 46 0.0008
402 VENTRICULAR FIBRILLATION 9 0.0008
403 WHITE BLOOD CELL COUNT INCREASED 31 0.0008
404 PNEUMONIA 261 0.0008
405 BLOOD PRESSURE ABNORMAL 16 0.0008
406 INFUSION SITE EXTRAVASATION 5 0.0008
407 RESPIRATORY DISORDER 24 0.0008
408 SKIN LESION 22 0.0008
409 SALIVARY HYPERSECRETION 8 0.0008
410 BLOOD CALCIUM INCREASED 7 0.0008
411 DYSARTHRIA 30 0.0008
412 HEART RATE IRREGULAR 18 0.0008
413 DIZZINESS 397 0.0008
414 GRIP STRENGTH DECREASED 7 0.0008
415 BLOOD TRIGLYCERIDES INCREASED 14 0.0008
416 LYMPHOCYTE COUNT DECREASED 14 0.0008
417 MUSCULAR WEAKNESS 90 0.0008
418 HYPOMAGNESAEMIA 11 0.0008
419 GASTRIC ULCER 15 0.0008
420 APHONIA 11 0.0008
421 DIABETES MELLITUS 60 0.0008
422 CARPAL TUNNEL SYNDROME 11 0.0008
423 BOWEL MOVEMENT IRREGULARITY 6 0.0008
424 LIPASE INCREASED 6 0.0008
425 NASAL CONGESTION 46 0.0008
426 PULMONARY OEDEMA 35 0.0008
427 ANAEMIA 149 0.0008
428 CONTUSION 75 0.0008
429 GLAUCOMA 15 0.0008
430 ERECTILE DYSFUNCTION 20 0.0008
431 TEMPERATURE INTOLERANCE 8 0.0008
432 VASCULITIS 9 0.0008
433 MELAENA 17 0.0008
434 PELVIC FRACTURE 6 0.0008
435 WEIGHT DECREASED 215 0.0008
436 HAEMORRHAGIC STROKE 6 0.0008
437 PULMONARY HYPERTENSION 16 0.0008
438 TENDERNESS 8 0.0008
439 CHOLELITHIASIS 25 0.0008
440 HAEMATOCHEZIA 42 0.0008
441 SUDDEN DEATH 8 0.0008
442 MYOCLONUS 9 0.0008
443 APPETITE DISORDER 5 0.0008
444 GINGIVAL PAIN 6 0.0008
445 CYSTITIS 24 0.0008
446 OSTEOPOROSIS 31 0.0008
447 DECREASED APPETITE 175 0.0008
448 CARDIAC FAILURE ACUTE 5 0.0007
449 RETCHING 16 0.0007
450 EYE HAEMORRHAGE 10 0.0007
451 BLOOD DISORDER 6 0.0007
452 DIARRHOEA HAEMORRHAGIC 7 0.0007
453 MUSCULOSKELETAL PAIN 39 0.0007
454 CARDIOMYOPATHY 11 0.0007
455 POOR QUALITY SLEEP 16 0.0007
456 LEUKAEMIA 7 0.0007
457 BURSITIS 9 0.0007
458 PERIPHERAL SWELLING 114 0.0007
459 METASTASES TO LIVER 13 0.0007
460 CATARACT 44 0.0007
461 CONFUSIONAL STATE 119 0.0007
462 LIMB INJURY 20 0.0007
463 PERICARDIAL EFFUSION 17 0.0007
464 DIABETES MELLITUS INADEQUATE CONTROL 13 0.0007
465 BONE DENSITY DECREASED 23 0.0007
466 PULMONARY THROMBOSIS 8 0.0007
467 LOSS OF CONSCIOUSNESS 94 0.0007
468 ABNORMAL LOSS OF WEIGHT 5 0.0007
469 HAEMATOMA 19 0.0007
470 CHEST DISCOMFORT 75 0.0007
471 DISORIENTATION 29 0.0007
472 BLOOD POTASSIUM DECREASED 22 0.0007
473 PERIPHERAL COLDNESS 10 0.0007
474 CYST 9 0.0007
475 DELIRIUM 25 0.0007
476 HIP ARTHROPLASTY 11 0.0007
477 HAEMORRHOIDS 14 0.0007
478 CHOKING 14 0.0007
479 NECK PAIN 40 0.0007
480 DEMENTIA 20 0.0007
481 RESTLESS LEGS SYNDROME 13 0.0007
482 GLYCOSYLATED HAEMOGLOBIN INCREASED 18 0.0007
483 KNEE ARTHROPLASTY 15 0.0007
484 LABORATORY TEST ABNORMAL 21 0.0007
485 MUSCULOSKELETAL CHEST PAIN 11 0.0007
486 TENDONITIS 11 0.0007
487 CHROMATURIA 16 0.0007
488 CEREBROVASCULAR ACCIDENT 120 0.0007
489 BLOOD GLUCOSE DECREASED 34 0.0007
490 SEASONAL ALLERGY 10 0.0007
491 IMPAIRED DRIVING ABILITY 8 0.0007
492 UPPER LIMB FRACTURE 14 0.0007
493 DYSGEUSIA 52 0.0007
494 DYSPNOEA 395 0.0007
495 INTENTIONAL PRODUCT USE ISSUE 61 0.0007
496 PLATELET COUNT DECREASED 74 0.0007
497 PNEUMOTHORAX 11 0.0007
498 MYOCARDIAL INFARCTION 121 0.0007
499 CARDIAC MURMUR 6 0.0007
500 DEEP VEIN THROMBOSIS 45 0.0007
501 DYSPEPSIA 68 0.0007
502 NODULE 9 0.0007
503 LOCAL SWELLING 12 0.0007
504 RASH MACULAR 24 0.0007
505 URINE OUTPUT DECREASED 6 0.0007
506 SLUGGISHNESS 7 0.0007
507 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
508 GASTROENTERITIS 10 0.0007
509 SPINAL PAIN 8 0.0007
510 ORAL DISORDER 5 0.0007
511 HYPOXIA 24 0.0007
512 ASTHMA 77 0.0007
513 COLD SWEAT 12 0.0007
514 PANCYTOPENIA 38 0.0007
515 CEREBRAL DISORDER 5 0.0007
516 TOOTH DISORDER 15 0.0007
517 BACTERAEMIA 8 0.0007
518 HAIR TEXTURE ABNORMAL 9 0.0007
519 MULTIPLE FRACTURES 11 0.0007
520 URINARY TRACT INFECTION 114 0.0007
521 RHINORRHOEA 43 0.0007
522 BREAST TENDERNESS 5 0.0007
523 LACRIMATION INCREASED 20 0.0007
524 PRODUCT SUBSTITUTION ISSUE 38 0.0007
525 UNRESPONSIVE TO STIMULI 17 0.0007
526 ACTIVITIES OF DAILY LIVING IMPAIRED 13 0.0007
527 BREAST PAIN 7 0.0007
528 VISION BLURRED 90 0.0007
529 CEREBRAL INFARCTION 16 0.0007
530 SEPSIS 73 0.0007
531 BACK PAIN 152 0.0007
532 MUSCLE SPASMS 119 0.0006
533 INJECTION SITE EXTRAVASATION 8 0.0006
534 CONJUNCTIVITIS 12 0.0006
535 BIPOLAR DISORDER 7 0.0006
536 LETHARGY 37 0.0006
537 HAIR COLOUR CHANGES 8 0.0006
538 CARDIAC DISORDER 60 0.0006
539 OESOPHAGITIS 7 0.0006
540 PARANOIA 11 0.0006
541 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
542 DENTAL CARIES 7 0.0006
543 DYSPHONIA 37 0.0006
544 CHEST PAIN 117 0.0006
545 RESPIRATORY FAILURE 46 0.0006
546 NASAL DISCOMFORT 5 0.0006
547 RESPIRATORY TRACT CONGESTION 10 0.0006
548 HYPOACUSIS 27 0.0006
549 DIARRHOEA 403 0.0006
550 THERAPEUTIC RESPONSE UNEXPECTED 28 0.0006
551 COUGH 175 0.0006
552 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
553 MYELODYSPLASTIC SYNDROME 9 0.0006
554 BRONCHITIS 46 0.0006
555 HYPERCHOLESTEROLAEMIA 6 0.0006
556 UNEVALUABLE EVENT 47 0.0006
557 HYPERHIDROSIS 80 0.0006
558 NIGHT SWEATS 20 0.0006
559 ABDOMINAL DISCOMFORT 104 0.0006
560 SKIN ULCER 16 0.0006
561 INJECTION SITE INDURATION 8 0.0006
562 HEPATIC FUNCTION ABNORMAL 23 0.0006
563 DRY MOUTH 50 0.0006
564 MYOCARDIAL ISCHAEMIA 7 0.0006
565 FATIGUE 478 0.0006
566 DECUBITUS ULCER 5 0.0006
567 JOINT SWELLING 74 0.0006
568 KIDNEY INFECTION 12 0.0006
569 STOMATITIS 37 0.0006
570 HYPERAESTHESIA 5 0.0006
571 PHOTOSENSITIVITY REACTION 10 0.0006
572 COLON CANCER 9 0.0006
573 ACUTE CORONARY SYNDROME 5 0.0006
574 ELECTROLYTE IMBALANCE 7 0.0006
575 EMBOLISM 5 0.0006
576 PRURITUS GENERALISED 13 0.0006
577 BONE LOSS 9 0.0006
578 CARDIAC FAILURE 48 0.0006
579 ARTHRITIS 47 0.0006
580 QUALITY OF LIFE DECREASED 8 0.0006
581 GAIT DISTURBANCE 114 0.0006
582 OROPHARYNGEAL PAIN 55 0.0006
583 HYPERSOMNIA 17 0.0006
584 HAEMATEMESIS 15 0.0006
585 HEMIPARESIS 10 0.0006
586 PULMONARY EMBOLISM 56 0.0006
587 TOOTH ABSCESS 6 0.0006
588 CEREBRAL HAEMORRHAGE 21 0.0006
589 THROMBOSIS 47 0.0006
590 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 15 0.0006
591 LYMPHOMA 9 0.0006
592 DRUG DOSE OMISSION 96 0.0006
593 PAIN IN EXTREMITY 171 0.0006
594 FOOT FRACTURE 11 0.0006
595 BLOOD CHOLESTEROL INCREASED 27 0.0006
596 NIGHTMARE 20 0.0006
597 DIPLOPIA 15 0.0006
598 ADRENAL INSUFFICIENCY 7 0.0006
599 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 41 0.0006
600 RESTLESSNESS 21 0.0006
601 PULMONARY FIBROSIS 11 0.0006
602 THROMBOCYTOPENIA 64 0.0006
603 CYTOPENIA 7 0.0006
604 EXPIRED PRODUCT ADMINISTERED 19 0.0006
605 BLOOD TEST ABNORMAL 8 0.0006
606 POOR QUALITY PRODUCT ADMINISTERED 6 0.0006
607 TINNITUS 26 0.0006
608 GENERALISED OEDEMA 7 0.0006
609 ORAL HERPES 11 0.0006
610 SKIN FISSURES 11 0.0006
611 THIRST 10 0.0006
612 ANGINA PECTORIS 16 0.0006
613 GASTROINTESTINAL INFECTION 5 0.0006
614 FEAR 15 0.0006
615 BURNING SENSATION 39 0.0006
616 BRAIN OEDEMA 7 0.0006
617 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
618 ANOSMIA 8 0.0006
619 BLISTER 31 0.0006
620 SKIN LACERATION 6 0.0006
621 PALLOR 15 0.0006
622 DRUG EFFECT INCOMPLETE 20 0.0006
623 LIMB DISCOMFORT 17 0.0005
624 ARRHYTHMIA 26 0.0005
625 PANCREATITIS 29 0.0005
626 METASTASES TO BONE 9 0.0005
627 HAEMORRHAGE 57 0.0005
628 HOT FLUSH 41 0.0005
629 FEEDING DISORDER 11 0.0005
630 TASTE DISORDER 11 0.0005
631 DRY EYE 27 0.0005
632 THINKING ABNORMAL 10 0.0005
633 ABDOMINAL DISTENSION 56 0.0005
634 MENTAL IMPAIRMENT 13 0.0005
635 MIDDLE INSOMNIA 10 0.0005
636 RASH PRURITIC 29 0.0005
637 DEFORMITY 5 0.0005
638 SKIN INFECTION 6 0.0005
639 NEURALGIA 13 0.0005
640 BLOOD CALCIUM DECREASED 6 0.0005
641 FLANK PAIN 5 0.0005
642 BEDRIDDEN 7 0.0005
643 PHOTOPHOBIA 10 0.0005
644 NASOPHARYNGITIS 98 0.0005
645 ORAL CANDIDIASIS 7 0.0005
646 MEMORY IMPAIRMENT 73 0.0005
647 SEPTIC SHOCK 23 0.0005
648 NEUROPATHY PERIPHERAL 50 0.0005
649 GASTRIC HAEMORRHAGE 6 0.0005
650 EYE DISORDER 17 0.0005
651 ANKLE FRACTURE 8 0.0005
652 EATING DISORDER 11 0.0005
653 DYSPHAGIA 49 0.0005
654 POST PROCEDURAL HAEMORRHAGE 6 0.0005
655 STAPHYLOCOCCAL INFECTION 17 0.0005
656 SWOLLEN TONGUE 16 0.0005
657 CHILLS 60 0.0005
658 VISUAL ACUITY REDUCED 17 0.0005
659 DEPRESSION 116 0.0005
660 VERTIGO 31 0.0005
661 HEAD DISCOMFORT 9 0.0005
662 KNEE OPERATION 5 0.0005
663 PRODUCT USE COMPLAINT 8 0.0005
664 TREMOR 84 0.0005
665 PRODUCT DISPENSING ERROR 11 0.0005
666 HERPES ZOSTER 29 0.0005
667 MEDICATION ERROR 28 0.0005
668 RASH GENERALISED 13 0.0005
669 HYPOAESTHESIA 75 0.0005
670 WRIST FRACTURE 6 0.0005
671 INSOMNIA 133 0.0005
672 WHITE BLOOD CELL COUNT DECREASED 54 0.0005
673 INJURY 35 0.0005
674 SPEECH DISORDER 26 0.0005
675 PAIN IN JAW 14 0.0005
676 BLOOD GLUCOSE INCREASED 93 0.0005
677 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 35 0.0005
678 RASH PAPULAR 11 0.0005
679 BODY TEMPERATURE INCREASED 10 0.0005
680 NEUTROPHIL COUNT INCREASED 5 0.0005
681 EUPHORIC MOOD 5 0.0005
682 IMPAIRED HEALING 16 0.0005
683 EAR DISCOMFORT 5 0.0005
684 THERAPY CESSATION 25 0.0005
685 PARAESTHESIA ORAL 7 0.0005
686 TOOTH LOSS 10 0.0005
687 TOOTH EXTRACTION 6 0.0005
688 LYMPHADENOPATHY 17 0.0005
689 SKIN DISORDER 16 0.0005
690 UNDERDOSE 35 0.0005
691 COVID-19 84 0.0005
692 EYE PAIN 27 0.0005
693 ROAD TRAFFIC ACCIDENT 20 0.0005
694 GENERAL PHYSICAL HEALTH DETERIORATION 55 0.0005
695 TREATMENT NONCOMPLIANCE 26 0.0005
696 ABDOMINAL PAIN LOWER 12 0.0005
697 DRUG ADMINISTERED AT INAPPROPRIATE SITE 5 0.0005
698 WEIGHT INCREASED 106 0.0005
699 SKIN HAEMORRHAGE 7 0.0005
700 EMOTIONAL DISTRESS 57 0.0005
701 SINUSITIS 48 0.0005
702 INTENTIONAL PRODUCT MISUSE 41 0.0005
703 JOINT INJURY 10 0.0005
704 MALAISE 205 0.0005
705 ANXIETY 133 0.0005
706 FEELING COLD 13 0.0005
707 NEUTROPHIL COUNT DECREASED 19 0.0005
708 ERUCTATION 9 0.0005
709 DISEASE PROGRESSION 55 0.0005
710 HYPOAESTHESIA ORAL 7 0.0005
711 PRODUCT QUALITY ISSUE 63 0.0005
712 APHASIA 14 0.0005
713 BONE PAIN 27 0.0005
714 EYE SWELLING 17 0.0005
715 RASH 199 0.0005
716 GASTROINTESTINAL PAIN 5 0.0005
717 SARS-COV-2 TEST POSITIVE 6 0.0005
718 THYROID DISORDER 7 0.0005
719 INTESTINAL OBSTRUCTION 17 0.0005
720 NERVE INJURY 5 0.0004
721 SPINAL FRACTURE 9 0.0004
722 LUNG DISORDER 22 0.0004
723 JOINT RANGE OF MOTION DECREASED 6 0.0004
724 MALNUTRITION 5 0.0004
725 GLOSSODYNIA 10 0.0004
726 BRAIN FOG 7 0.0004
727 PAIN 274 0.0004
728 SNEEZING 10 0.0004
729 AMNESIA 29 0.0004
730 ABASIA 11 0.0004
731 ARTHRALGIA 185 0.0004
732 OSTEONECROSIS OF JAW 11 0.0004
733 FREQUENT BOWEL MOVEMENTS 12 0.0004
734 HEART RATE INCREASED 44 0.0004
735 SINUS CONGESTION 6 0.0004
736 MYALGIA 75 0.0004
737 APPLICATION SITE PRURITUS 10 0.0004
738 PNEUMONIA ASPIRATION 11 0.0004
739 ULCER 7 0.0004
740 PRODUCT AVAILABILITY ISSUE 10 0.0004
741 SCIATICA 7 0.0004
742 CHOLECYSTECTOMY 5 0.0004
743 FEBRILE NEUTROPENIA 29 0.0004
744 SOMNOLENCE 88 0.0004
745 MYOCARDITIS 5 0.0004
746 MOVEMENT DISORDER 14 0.0004
747 RESPIRATORY ARREST 12 0.0004
748 RESPIRATORY DISTRESS 12 0.0004
749 ORAL DISCOMFORT 6 0.0004
750 HEPATIC STEATOSIS 8 0.0004
751 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
752 PRODUCT DOSE OMISSION 28 0.0004
753 DRUG EFFECT DECREASED 23 0.0004
754 DEVICE OCCLUSION 6 0.0004
755 HALLUCINATION, VISUAL 9 0.0004
756 HYPONATRAEMIA 24 0.0004
757 PARAESTHESIA 67 0.0004
758 HEPATIC CIRRHOSIS 8 0.0004
759 VENTRICULAR TACHYCARDIA 7 0.0004
760 FEELING ABNORMAL 101 0.0004
761 ATAXIA 5 0.0004
762 ABDOMINAL PAIN 98 0.0004
763 BRONCHOSPASM 6 0.0004
764 FEELING JITTERY 8 0.0004
765 CHOLECYSTITIS 5 0.0004
766 PARALYSIS 6 0.0004
767 INCREASED APPETITE 8 0.0004
768 DRUG PRESCRIBING ERROR 8 0.0004
769 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
770 PRODUCT USE ISSUE 78 0.0004
771 CANDIDA INFECTION 7 0.0004
772 CONDITION AGGRAVATED 126 0.0004
773 ARTHROPATHY 23 0.0004
774 HYPOKINESIA 6 0.0004
775 WRONG TECHNIQUE IN DRUG USAGE PROCESS 15 0.0004
776 NEEDLE ISSUE 12 0.0004
777 EAR PAIN 8 0.0004
778 MUSCULOSKELETAL STIFFNESS 36 0.0004
779 COMPLETED SUICIDE 34 0.0004
780 MUSCLE SPASTICITY 5 0.0004
781 TACHYCARDIA 36 0.0004
782 DISABILITY 8 0.0004
783 MOBILITY DECREASED 29 0.0004
784 HEADACHE 253 0.0004
785 ABDOMINAL PAIN UPPER 83 0.0004
786 SKIN EXFOLIATION 34 0.0004
787 APPLICATION SITE IRRITATION 5 0.0004
788 PRESCRIBED UNDERDOSE 8 0.0004
789 INFECTION 58 0.0004
790 ABNORMAL DREAMS 11 0.0004
791 DEATH 343 0.0004
792 DIVERTICULITIS 11 0.0004
793 SLEEP DISORDER 28 0.0004
794 PRODUCT PHYSICAL ISSUE 8 0.0004
795 COLITIS 15 0.0004
796 VISUAL IMPAIRMENT 49 0.0004
797 SWELLING 37 0.0004
798 ILL-DEFINED DISORDER 24 0.0004
799 DRUG ERUPTION 7 0.0004
800 MUSCLE ATROPHY 5 0.0004
801 INFLUENZA 44 0.0004
802 BONE MARROW FAILURE 8 0.0004
803 PALPITATIONS 46 0.0004
804 DRUG DISPENSING ERROR 6 0.0004
805 INTRAOCULAR PRESSURE INCREASED 5 0.0004
806 DRUG ADMINISTRATION ERROR 12 0.0004
807 FUNGAL INFECTION 13 0.0004
808 DEVICE RELATED INFECTION 6 0.0004
809 INFUSION SITE PAIN 5 0.0004
810 GYNAECOMASTIA 12 0.0004
811 PRURITUS 149 0.0004
812 TOOTHACHE 7 0.0004
813 ACUTE MYELOID LEUKAEMIA 6 0.0004
814 ANGIOEDEMA 17 0.0004
815 SWELLING FACE 25 0.0004
816 DEAFNESS 10 0.0004
817 EYE IRRITATION 22 0.0004
818 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
819 IMMUNE SYSTEM DISORDER 5 0.0004
820 GASTRIC DISORDER 13 0.0004
821 DISEASE RECURRENCE 18 0.0004
822 INFUSION RELATED REACTION 25 0.0004
823 ADVERSE REACTION 5 0.0004
824 ABSCESS 6 0.0004
825 PYREXIA 130 0.0004
826 ALANINE AMINOTRANSFERASE INCREASED 23 0.0004
827 NAUSEA 296 0.0004
828 DRUG INEFFECTIVE 488 0.0004
829 DYSKINESIA 15 0.0004
830 HYPOKALAEMIA 17 0.0004
831 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
832 POST PROCEDURAL COMPLICATION 7 0.0004
833 THERAPEUTIC RESPONSE DECREASED 22 0.0004
834 DRUG LEVEL INCREASED 6 0.0004
835 PRESCRIBED OVERDOSE 7 0.0004
836 VIRAL INFECTION 12 0.0004
837 OFF LABEL USE 315 0.0004
838 VOMITING 169 0.0004
839 DEPRESSED MOOD 19 0.0004
840 HUNGER 5 0.0004
841 CARDIO-RESPIRATORY ARREST 15 0.0004
842 PANIC ATTACK 13 0.0004
843 THROAT IRRITATION 16 0.0004
844 PANCREATITIS ACUTE 8 0.0004
845 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
846 INJECTION SITE MASS 13 0.0004
847 MALIGNANT NEOPLASM PROGRESSION 36 0.0004
848 INCORRECT DOSE ADMINISTERED 80 0.0004
849 IMPAIRED QUALITY OF LIFE 5 0.0003
850 APATHY 5 0.0003
851 SURGERY 20 0.0003
852 LUNG NEOPLASM MALIGNANT 14 0.0003
853 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 61 0.0003
854 THERAPY NON-RESPONDER 15 0.0003
855 BLOOD BILIRUBIN INCREASED 9 0.0003
856 THROAT TIGHTNESS 9 0.0003
857 HEPATIC FAILURE 10 0.0003
858 LIP SWELLING 11 0.0003
859 NEOPLASM MALIGNANT 22 0.0003
860 GAIT INABILITY 11 0.0003
861 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
862 DISCOMFORT 20 0.0003
863 ENCEPHALOPATHY 8 0.0003
864 NERVOUSNESS 17 0.0003
865 BLOOD GLUCOSE ABNORMAL 6 0.0003
866 PROCEDURAL PAIN 9 0.0003
867 PROSTATE CANCER 26 0.0003
868 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
869 DELUSION 5 0.0003
870 BACTERIAL INFECTION 6 0.0003
871 EXTRA DOSE ADMINISTERED 13 0.0003
872 ILLNESS 33 0.0003
873 APPLICATION SITE PAIN 7 0.0003
874 HYPOCALCAEMIA 6 0.0003
875 OCULAR HYPERAEMIA 15 0.0003
876 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
877 MUSCULOSKELETAL DISORDER 6 0.0003
878 HALLUCINATION, AUDITORY 5 0.0003
879 HEPATITIS 8 0.0003
880 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
881 ADVERSE DRUG REACTION 28 0.0003
882 URTICARIA 52 0.0003
883 FEELING HOT 19 0.0003
884 NEUTROPENIA 42 0.0003
885 TOXICITY TO VARIOUS AGENTS 52 0.0003
886 MULTIPLE SCLEROSIS RELAPSE 21 0.0003
887 ASCITES 9 0.0003
888 SUICIDAL IDEATION 28 0.0003
889 APPLICATION SITE ERYTHEMA 8 0.0003
890 SKIN DISCOLOURATION 14 0.0003
891 GASTRITIS 8 0.0003
892 MUSCLE TWITCHING 7 0.0003
893 HYPERSENSITIVITY 56 0.0003
894 GASTROINTESTINAL DISORDER 27 0.0003
895 COGNITIVE DISORDER 14 0.0003
896 AGGRESSION 15 0.0003
897 IRRITABILITY 18 0.0003
898 EYE PRURITUS 10 0.0003
899 PSORIATIC ARTHROPATHY 12 0.0003
900 BLINDNESS 12 0.0003
901 MOOD ALTERED 8 0.0003
902 INFLUENZA LIKE ILLNESS 24 0.0003
903 RHEUMATOID ARTHRITIS 33 0.0003
904 MULTI-ORGAN FAILURE 5 0.0003
905 DERMATITIS 6 0.0003
906 WOUND 8 0.0003
907 FLUSHING 29 0.0003
908 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
909 HYPOTHYROIDISM 9 0.0003
910 INTENTIONAL DOSE OMISSION 8 0.0003
911 THERAPY INTERRUPTED 20 0.0003
912 CONVULSION 16 0.0003
913 DRUG INTOLERANCE 27 0.0003
914 DISTURBANCE IN ATTENTION 15 0.0003
915 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
916 INJECTION SITE HAEMORRHAGE 22 0.0003
917 AGITATION 20 0.0003
918 DRY SKIN 36 0.0003
919 SEIZURE 31 0.0003
920 PSORIASIS 35 0.0003
921 MUCOSAL INFLAMMATION 7 0.0003
922 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
923 EAR INFECTION 7 0.0003
924 ADVERSE EVENT 24 0.0003
925 HOSPITALISATION 40 0.0003
926 ANAPHYLACTIC REACTION 14 0.0003
927 MENTAL DISORDER 11 0.0003
928 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
929 METABOLIC ACIDOSIS 8 0.0002
930 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
931 ALOPECIA 48 0.0002
932 OSTEONECROSIS 8 0.0002
933 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 49 0.0002
934 LEUKOPENIA 12 0.0002
935 MOUTH ULCERATION 5 0.0002
936 RESPIRATORY TRACT INFECTION 6 0.0002
937 JOINT STIFFNESS 6 0.0002
938 ERYTHEMA 47 0.0002
939 JAUNDICE 6 0.0002
940 HEPATIC ENZYME INCREASED 15 0.0002
941 C-REACTIVE PROTEIN INCREASED 8 0.0002
942 PRODUCT DOSE OMISSION ISSUE 64 0.0002
943 TARDIVE DYSKINESIA 6 0.0002
944 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
945 RASH ERYTHEMATOUS 10 0.0002
946 PANCREATIC CARCINOMA 6 0.0002
947 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
948 INJECTION SITE PAIN 60 0.0002
949 EMOTIONAL DISORDER 6 0.0002
950 INFLAMMATION 10 0.0002
951 FEMUR FRACTURE 6 0.0002
952 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 9 0.0002
953 ACCIDENTAL OVERDOSE 7 0.0002
954 INCORRECT DOSE ADMINISTERED BY DEVICE 5 0.0002
955 WITHDRAWAL SYNDROME 8 0.0002
956 MOOD SWINGS 6 0.0002
957 MULTIPLE SCLEROSIS 9 0.0002
958 COLITIS ULCERATIVE 8 0.0002
959 MIGRAINE 17 0.0002
960 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
961 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
962 SKIN IRRITATION 8 0.0002
963 LIVER FUNCTION TEST ABNORMAL 5 0.0002
964 DEVICE MALFUNCTION 12 0.0002
965 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
966 INJECTION SITE SWELLING 13 0.0002
967 COMA 8 0.0002
968 CRYING 6 0.0002
969 OVERDOSE 35 0.0002
970 PRODUCT USE IN UNAPPROVED INDICATION 40 0.0002
971 LIVER DISORDER 7 0.0002
972 ECZEMA 8 0.0002
973 BLADDER CANCER 9 0.0002
974 ABNORMAL BEHAVIOUR 6 0.0002
975 SUICIDE ATTEMPT 9 0.0001
976 DEVICE ISSUE 13 0.0001
977 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
978 NO ADVERSE EVENT 25 0.0001
979 INJECTION SITE ERYTHEMA 17 0.0001
980 DRUG WITHDRAWAL SYNDROME 12 0.0001
981 ACNE 10 0.0001
982 INJECTION SITE REACTION 9 0.0001
983 ACCIDENTAL EXPOSURE TO PRODUCT 13 0.0001
984 INJECTION SITE BRUISING 10 0.0001
985 DEVICE LEAKAGE 5 0.0001
986 SKIN BURNING SENSATION 8 0.0001
987 DRUG ABUSE 9 0.0001
988 INTERSTITIAL LUNG DISEASE 5 0.0001
989 PRODUCT STORAGE ERROR 9 0.0001
990 INJECTION SITE PRURITUS 6 0.0001
991 TREATMENT FAILURE 7 0.0001
992 INTENTIONAL OVERDOSE 5 0.0001
993 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
994 DRUG DEPENDENCE 9 0.0001